Thomas Lübbig has been a partner of Freshfields Bruckhaus Deringer since 2001 and works in the Berlin office. He is a member of our antitrust, competition and trade (ACT) practice group and specialises in EU law, in particular EU competition law, state aid law, questions of the European domestic market, German competition law and economic administrative law. He represents clients regularly before the European Court of First Instance and the European Court of Justice. He has experience in the following sectors: pharmaceuticals, chemicals, building materials industry, gas and water, media, railway, logistics and transport. Thomas was born in Berlin in 1967. After training as a qualified bank clerk, he studied law at the universities of Trier, Lyon, Geneva and Berlin. He holds a Doctor of Laws (Dr iur) degree from the Freie Universität Berlin. He worked at a management consultancy firm in Johannesburg for one year before joining the Berlin office of Deringer Tessin Herrmann.
111
The European Court of Justice ( CJEU ) handed down its judgment in Towercast on 16 March 2023, confirming Advocate General Juliane Kokott’s Opinion from October 2022 that the prohibition on abuse of dominance under Article 102 TFEU is applicable to certain non-reportable mergers by dominant (...)
219
Shortly before the end of 2021, the Austrian Federal Competition Authority (Bundeswettbewerbsbehörde, BWB) and the German Federal Cartel Office (Bundeskartellamt, BKA) published revised guidance on the interpretation of the transaction value-based thresholds in Austrian and German merger control (...)
102
Exclusivity rebates are used in markets ranging from postal deliveries through ice cream to computer processors and are normally regarded as beneficial to consumers. However, when applied by dominant companies such rebates could potentially entrench an existing market position and have been (...)
4692
Following the European Commission’s decision regarding the vitamin cartel (Commission Decision 2003/2/EC, of 21 November 2001, relating to a proceeding pursuant to Article 81 of the EC Treaty and Article 53 of the EEA Agreement (Case COMP/E-1/37.512 - Vitamins), OJEC L 6, 10 January 2003, pp. (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
